Nearly 300 abstracts on prostate cancer research from around the world will be presented at the European Association of Urology Congress (EAU26 ...

Nearly 300 abstracts on prostate cancer research from around the world will be presented at the European Association of Urology Congress (EAU26), taking place in London from 13–16 March 2026.

URO-1, Inc. is a life sciences company dedicated to advancing the tools and workflows used in soft tissue biopsy diagnostics.

Prostate cancer (PCa) detection using deep learning (DL) models has shown potential for enhancing real-time guidance during biopsies. However, prostate ultrasound images lack pixel-level cancer ...

Introduction: Prostate cancer (PCa) is the second most common type of cancer among the male population. Men carrying mutations in the BRCA1 and BRCA2 genes are known to have a greater risk of ...

Abstract: Robotic-assisted medical procedures require precise needle tip detection. This is especially important in treatments like prostate brachytherapy. Traditional ultrasound-based manual ...

Introduction Facing the profound health impacts and economic challenges posed by the high maternal mortality ratio worldwide, point-of-care ultrasound (POCUS) has shown its potential to enhance ...

Focused ultrasound uses energy from sound waves to precisely target tissues and create lesions (areas of damaged tissue). FUS can be used in the brain to help interrupt abnormal brain activity related ...

Heart failure (HF) is one of the most frequent and clinically important causes of dyspnea, and its recognition in primary care is often hindered by limited access to advanced diagnostics. This study ...